Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA

Latest

The CPG Guys: Building a world class retail media platform with Walmart Connect’s Jeff Clark
Jeff Clark is the VP of Product & Commercialization at Walmart Connect, Walmart's retail media division.

Pop-Tarts teams with new Fantastic Four movie
The Crazy Good collaboration unleashes a FanTASTEic snacking experience with four total movie-inspired toaster pastry flavors.

Ulta’s “Unleashed” plan pays off as Q1 sales rise 4.5%
The initiative included streamlining operations, updating stores and inventory, and improving marketing and promotional execution.

FMI to launch Supply Chain Exchange at upcoming forum
The new format will offer curated, one-on-one meetings between retailers, suppliers, and service providers, matched based on shared business challenges.